MAXIMUS, Inc. (NYSE:MMS) declared a quarterly dividend on Thursday, April 11th, Wall Street Journal reports. Shareholders of record on Wednesday, May 15th will be paid a dividend of 0.25 per share by the health services provider on Friday, May 31st. This represents a $1.00 annualized dividend and a yield of 1.42%. The ex-dividend date of this dividend is Tuesday, May 14th.

MAXIMUS has raised its dividend by an average of 28.8% per year over the last three years. MAXIMUS has a payout ratio of 30.9% meaning its dividend is sufficiently covered by earnings. Research analysts expect MAXIMUS to earn $4.11 per share next year, which means the company should continue to be able to cover its $1.00 annual dividend with an expected future payout ratio of 24.3%.

Shares of NYSE MMS traded down $0.39 during midday trading on Thursday, hitting $70.32. The company’s stock had a trading volume of 155,521 shares, compared to its average volume of 345,344. The firm has a market cap of $4.48 billion, a price-to-earnings ratio of 20.68, a PEG ratio of 1.92 and a beta of 0.96. MAXIMUS has a 1 year low of $60.00 and a 1 year high of $73.81. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.32 and a current ratio of 2.32.

MAXIMUS (NYSE:MMS) last posted its quarterly earnings data on Thursday, February 7th. The health services provider reported $0.86 earnings per share for the quarter, beating analysts’ consensus estimates of $0.80 by $0.06. MAXIMUS had a net margin of 8.94% and a return on equity of 20.09%. The firm had revenue of $664.60 million for the quarter, compared to analyst estimates of $672.08 million. During the same period last year, the firm posted $0.89 EPS. MAXIMUS’s quarterly revenue was up 6.7% on a year-over-year basis. Equities analysts predict that MAXIMUS will post 3.66 EPS for the current fiscal year.

In other news, Director Paul R. Lederer sold 6,715 shares of the business’s stock in a transaction on Wednesday, February 13th. The stock was sold at an average price of $70.04, for a total transaction of $470,318.60. Following the completion of the sale, the director now owns 59,029 shares in the company, valued at $4,134,391.16. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Russell A. Beliveau sold 1,000 shares of MAXIMUS stock in a transaction on Monday, April 1st. The stock was sold at an average price of $71.40, for a total value of $71,400.00. The disclosure for this sale can be found here. Insiders have sold a total of 54,715 shares of company stock worth $3,873,949 in the last three months. 2.20% of the stock is owned by insiders.

A number of equities analysts have weighed in on the company. Zacks Investment Research upgraded MAXIMUS from a “hold” rating to a “buy” rating and set a $78.00 price target for the company in a report on Tuesday, February 12th. ValuEngine lowered MAXIMUS from a “buy” rating to a “hold” rating in a research report on Thursday, February 28th.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally posted by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another website, it was copied illegally and reposted in violation of US and international trademark and copyright legislation. The original version of this piece of content can be read at https://www.watchlistnews.com/maximus-inc-mms-declares-quarterly-dividend-of-0-25/2955764.html.

About MAXIMUS

MAXIMUS, Inc provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews.

Featured Story: What Does Beta Mean In Stock Selection

Dividend History for MAXIMUS (NYSE:MMS)

Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.